Hemorheological Parameters in Some Vascular Diseases

  • J. F. Stoltz
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 164)


The origin of arterial diseases (acrosyndromes or peripheral vascular diseases is undoubtedly more generally attributed to parietal and vasomotor anomalies than to hemorheological disorders. However, in the light of recent investigations it would seem that increased erythrocyte aggregation is generally observed during arterial disease and is sometimes accompanied by reduced red cell deformability resulting in the appearance of a hyperviscosity syndrome. These rheological disturbances may have very significant bearing on the complications observed via three primary mechanisms: hemolysis (resulting in ADP release and promoting platelet aggregation), erythrocyte aggregation (resulting in a decreased blood flow (sludge)), and reduced erythrocyte deformability accompanied by reduced oxygen availability in the small blood vessels.


Peripheral Arterial Disease Blood Viscosity Intermittent Claudication Plasma Viscosity Erythrocyte Aggregation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    I. Anadere, H. Chmiel, H. Hess, G.B. Thurston, Clinical blood rheology. Biorheology 16:171–178 (1979).PubMedGoogle Scholar
  2. 2.
    L. Dintenfass, Hemorheological factors in Raynaud’s phenomenon. Angiology 28:472–481 (1977).PubMedCrossRefGoogle Scholar
  3. 3.
    L. Dintenfass, L.S. Ibels, Blood viscosity factors and occlusive arterial disease in renal transplant recipients. Nephron 15: 456–465 (1975).PubMedCrossRefGoogle Scholar
  4. 4.
    A.J. Dodds, M.J.G. O’Reilly, C.J.P. Yates, L.T. Catton, P.T. Flute, J.A. Dormandy, Haemorheological response to plasma exchange in Raynaud’s syndrome. Br. Med. J. 1186–1187 (1979).Google Scholar
  5. 5.
    J.A. Dormandy, E. Hoare, J. Colley, D.E. Arrowsmith, T.L. Dormandy, Clinical, haemodynamic, rheological and biochemical findings in 126 patients with intermittent claudication. Br. Med. J. 4:576–581 (1973).PubMedCrossRefGoogle Scholar
  6. 6.
    J.A. Dormandy, J.M.C. Gutteridge, E. Hoare, T.L. Dormandy, Effect of Clofibrate on blood viscosity in intermittent claudication. Br. Med. J. 4:259–262 (1974).PubMedCrossRefGoogle Scholar
  7. 7.
    J. A. Dormandy, E. Hoare, J. Postlethwaite, Blood viscosity of patients with intermittent claudication — concept of “rheological claudication”. Biorheology 13:161–164 (1976).PubMedGoogle Scholar
  8. 8.
    H. Ehringer, R. Dudczek, K. Lechner, A new approach in the treatment of peripheral arterial occlusions: Defibrination with Arvin. Angiology 25:279 (1974).PubMedCrossRefGoogle Scholar
  9. 9.
    A.M. Ehrly, Influence of arvin on the flow properties of blood. Biorheology 10:453 (1973).PubMedGoogle Scholar
  10. 10.
    A.M. Ehrly, H.J. Köhler, Impaired erythrocyte deformability in patients with chronic occlusive arterial disease. In: Abstract book, Xe International Congress of Angiology — Tokio 1976.Google Scholar
  11. 11.
    S. Forconi, M. Guerrini, D. Agnusdei, F. Laghi Pasini, T. Di Perri, Abnormal blood viscosity in Raynaud’s phenomenon. The Lancet 7985:586 (1976).CrossRefGoogle Scholar
  12. 12.
    T. Jahnsen, S.L. Nielsen, F. Skovborg, Blood viscosity and local response to cold in primary Raynaud’s phenomenon. The Lancet 1001–1002 (1977).Google Scholar
  13. 13.
    G.D.O. Lowe, J.J. Morrice, C.D. Forbes, C.R.M. Prentice, A.J. Fulton, J.C. Barbenel, Subcutaneous ancrod therapy in peripheral arterial disease: Improvement in blood viscosity and nutritional blood flow. Angiology 30:594 (1979a).PubMedCrossRefGoogle Scholar
  14. 14.
    G.D.O. Lowe, M.M. Reavey, R.V. Johnston, C.I.D. Forbes and C.R.M. Prentice, Increased platelet aggregates in vascular and non-vascular illness: Correlation with plasma fibrinogen and effect of ancrod. Thromb. Res. 14:377 (1979b).PubMedCrossRefGoogle Scholar
  15. 15.
    M.A. McGrath, R. Peek, R. Penny, Raynaud’s disease: Reduced hand blood flows with normal blood viscosity. Aust. N.Z.J. Med. 8: n°2, 126–131 (1978).PubMedCrossRefGoogle Scholar
  16. 16.
    Th. von Neuhann, Untersuchungen über Plättchenfunktion und Blutviskosität bei M. Raynaud und Sklerodermie. Fortschr. Med. 89:376–379 (1971).Google Scholar
  17. 17.
    R. Pringle, D.N. Walder, J.P.A. Weaver, Blood viscosity and Raynaud’s disease. The Lancet 1:1086–1089 (1965).CrossRefGoogle Scholar
  18. 18.
    H. Schmid-Schönbein, J. Weiss, E. Volger, H.J. Klose and H. Malotta, Microhaemorheology and defibrination. Zeitschrift fur Allegemeine Medizin 54:1635 (1978).Google Scholar
  19. 19.
    J.F. Stoltz, S. Gaillard, C. Schmidt, M. Verry, A. Larcan, F. Streiff, Viscosité sanguine et syndromes de Raynaud. Ann. Med. Nancy 19:209–212 (1980).Google Scholar
  20. 20.
    B. Stornier, R. Horsch, F. Kleinschmidt, D. Loose, H. Bruster, K. Kremer, Blood viscosity in patients with peripheral vascular disease in the area of low shear rates. J. Cardiovasc. Surg. 15:577–584 (1974).Google Scholar
  21. 21.
    G.W. Tiejen, S. Chien, E.C. Leroy, I. Gavras, H. Gavras, F.E. Gump, Blood viscosity, plasma proteins, and Raynaud syndrome. Arch. Surg. 110:1343–1346 (1975).CrossRefGoogle Scholar
  22. 22.
    H. Vinazzer, Zur Wirkung von Arvin auf die Blutgerinung. Wiener Zeitschrift für Inner Medizin 52:378 (1971).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • J. F. Stoltz
    • 1
  1. 1.Hemorheology DepartmentRegional Blood Transfusion Centre BarboisVandoeuvre-lès-NancyFrance

Personalised recommendations